7G BIOVENTURES MANAGEMENT COMPANY, LLC
7G BIOVENTURES MANAGEMENT COMPANY, LLC is a Series A fund in the US, Canada and Europe writing $250K–$10M checks into Healthcare, life-sciences, drug-discovery and biotechnology.
- Stages
- Series A
- Sectors
- Healthcare, life-sciences, drug-discovery, biotechnology
- Check size
- $250K–$10M
- Invests in
- US-wide, Canada, Europe
- Actively investing
- Yes
- Founded
- 2020
- Assets under management
- $32M
- Website
- 7gventures.com
Thesis
7G BioVentures is a venture capital firm founded in 2020 and based in Belmont, California. The firm focuses on investing in first-in-class life science innovations across the United States, Canada, and Europe. The firm primarily invests in Series A rounds within the life sciences sector, including drug discovery and biotechnology. 7G BioVentures aims to empower scientists, clinicians, and entrepreneurs to translate discoveries into life-saving products. Vincent Xiang's investment range is $250K - $10.0M, with a sweet spot of $1.5M. 7G BioVentures I LP had an AUM of $32.0 million as of January 26, 2022.
Common questions
Does 7G BIOVENTURES MANAGEMENT COMPANY, LLC invest at the Series A stage?
Yes. 7G BIOVENTURES MANAGEMENT COMPANY, LLC lists Series A among the stages it invests in.
What check size does 7G BIOVENTURES MANAGEMENT COMPANY, LLC write?
7G BIOVENTURES MANAGEMENT COMPANY, LLC writes $250K–$10M checks.
Where does 7G BIOVENTURES MANAGEMENT COMPANY, LLC invest?
7G BIOVENTURES MANAGEMENT COMPANY, LLC invests in the US, Canada and Europe.